These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16777556)

  • 1. Imaging liver metastases with a new oral manganese-based contrast agent.
    Chabanova E; Logager V; Moller JM; Dekker H; Barentsz J; Thomsen HS
    Acad Radiol; 2006 Jul; 13(7):827-32. PubMed ID: 16777556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manganese-based oral contrast agent for liver magnetic resonance imaging: evaluation of the time course and dose response of liver signal intensity enhancement.
    Rief M; Huppertz A; Asbach P; Franiel T; Schwenke C; Hamm B; Taupitz M; Wagner M
    Invest Radiol; 2010 Sep; 45(9):565-71. PubMed ID: 20644484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral manganese for liver imaging at three different field strengths.
    Thomsen HS; Loegager V; Noergaard H; Chabanova E; Moller JM; Sonne J
    Acad Radiol; 2004 Jun; 11(6):630-6. PubMed ID: 15172365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI of colorectal cancer liver metastases: comparison of orally administered manganese with intravenously administered gadobenate dimeglumine.
    Brismar TB; Kartalis N; Kylander C; Albiin N
    Eur Radiol; 2012 Mar; 22(3):633-41. PubMed ID: 21953376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new manganese-based oral contrast agent (CMC-001) for liver MRI: pharmacological and pharmaceutical aspects.
    Jørgensen JT; Rief M; Brismar TB; Wagner M; Albiin N
    Acta Radiol; 2012 Sep; 53(7):707-13. PubMed ID: 22821959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
    Sahani DV; Kalva SP; Fischman AJ; Kadavigere R; Blake M; Hahn PF; Saini S
    AJR Am J Roentgenol; 2005 Jul; 185(1):239-46. PubMed ID: 15972430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of new manganese contrast agent on tissue intensities in human volunteers: comparison of 0.23, 0.6 and 1.5 T MRI, a part of a phase I trial.
    Chabanova E; Thomsen HS; Løgager V; Moller JM; Brage K; Fogh K; Bovin J; Elmig J
    MAGMA; 2004 Sep; 17(1):28-35. PubMed ID: 15258827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C
    Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy of liver metastases. Comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning.
    Pech M; Mohnike K; Wieners G; Bialek E; Dudeck O; Seidensticker M; Peters N; Wust P; Gademann G; Ricke J
    Strahlenther Onkol; 2008 May; 184(5):256-61. PubMed ID: 18427756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWI.
    Eiber M; Holzapfel K; Ganter C; Epple K; Metz S; Geinitz H; Kübler H; Gaa J; Rummeny EJ; Beer AJ
    J Magn Reson Imaging; 2011 May; 33(5):1160-70. PubMed ID: 21509875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Manganese-DPDP in the MR tomography of malignant liver tumors. The initial results with a new hepatobiliary contrast agent].
    Steudel A; Layer G; Kraheck H; Hartlapp J; Reiser M
    Rofo; 1992 May; 156(5):460-4. PubMed ID: 1596550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases.
    Donati OF; Fischer MA; Chuck N; Hunziker R; Weishaupt D; Reiner CS
    Eur J Radiol; 2013 May; 82(5):822-8. PubMed ID: 23287713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Focal liver lesions. A comparison between magnetic resonance under base conditions and after a superparamagentic contrast medium].
    Finazzo M; Midiri M; Gallo C; Bartolotta TV; Luca A
    Radiol Med; 1998 Jun; 95(6):599-607. PubMed ID: 9717542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body MRI for metastases screening: a preliminary study using 3D VIBE sequences with automatic subtraction between noncontrast and contrast enhanced images.
    Thomson V; Pialat JB; Gay F; Coulon A; Voloch A; Granier A; Guérin JC; Viallon M; Berthezene Y
    Am J Clin Oncol; 2008 Jun; 31(3):285-92. PubMed ID: 18525309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation.
    Rappeport ED; Loft A; Berthelsen AK; von der Recke P; Larsen PN; Mogensen AM; Wettergren A; Rasmussen A; Hillingsoe J; Kirkegaard P; Thomsen C
    Acta Radiol; 2007 May; 48(4):369-78. PubMed ID: 17453514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial clinical experience with oral manganese (CMC-001) for liver MR imaging.
    Thomsen HS; Barentsz JO; Burcharth F; Chabanova E; Dekker HM; Moesgaard F; Moller JM; Leth-Espensen P; Logager V; Takahashi S
    Eur Radiol; 2007 Jan; 17(1):273-8. PubMed ID: 16763790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases.
    Chung WS; Kim MJ; Chung YE; Kim YE; Park MS; Choi JY; Kim KW
    J Magn Reson Imaging; 2011 Aug; 34(2):345-53. PubMed ID: 21702068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase-based manganese enhanced MRI, a new methodology to enhance brain cytoarchitectural contrast and study manganese uptake.
    Maddage R; Marques JP; Gruetter R
    Magn Reson Med; 2014 Nov; 72(5):1246-56. PubMed ID: 24259029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of liver malignancy with gadoxetic acid-enhanced MRI: is addition of diffusion-weighted MRI beneficial?
    Kim YK; Kim CS; Han YM; Lee YH
    Clin Radiol; 2011 Jun; 66(6):489-96. PubMed ID: 21367403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orally administered manganese with and without ascorbic acid as a liver-specific contrast agent and bowel marker for magnetic resonance imaging: phase I clinical trial assessing efficacy and safety.
    Leander P; Golman K; Månsson S; Höglund P
    Invest Radiol; 2010 Sep; 45(9):559-64. PubMed ID: 20644487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.